GNA11 variants identified in patients with hypercalcemia or hypocalcemia
Journal article
Howles S. et al, (2023), Journal of Bone and Mineral Research
Impact of COVID-19 on the management and outcomes of ureteric stones in the UK: a multicentre retrospective study.
Journal article
Byrne MHV. et al, (2022), BJU Int
Associations of adiposity, kidney stone disease, and serum calcium concentrations; observational and genetic epidemiological studies
Preprint
Lovegrove C. et al, (2022)
Author Correction: Genetic variants of calcium and vitamin D metabolism in kidney stone disease.
Journal article
Howles SA. et al, (2022), Nat Commun, 13
Natural history of small asymptomatic kidney and residual stones over a long-term follow-up: systematic review over 25 years.
Journal article
Lovegrove CE. et al, (2022), BJU Int, 129, 442 - 456
Utility of Blood Tests in Screening for Metabolic Disorders in Kidney Stone Disease
Journal article
Howles S. et al, (2020), British Journal of Urology (BJU) International
The COVID Stones Collaborative: How has the Management of Ureteric Stones Changed During and After the COVID-19 Pandemic? Rationale and Study Protocol.
Journal article
Georgiades F. et al, (2020), Journal of Endoluminal Endourology, 3, e22 - e28
Genetics of kidney stone disease.
Journal article
Howles SA. and Thakker RV., (2020), Nat Rev Urol, 17, 407 - 421
Genetic variants of calcium and vitamin D metabolism in kidney stone disease
Journal article
HOWLES S. et al, (2019), Nature Communications
Cinacalcet corrects hypercalcemia in mice with an inactivating Gα11 mutation.
Journal article
Howles SA. et al, (2017), JCI Insight, 2
Gα11 mutation in mice causes hypocalcemia rectifiable by calcilytic therapy.
Journal article
Gorvin CM. et al, (2017), JCI Insight, 2
Identification of a G-Protein Subunit-α11 Gain-of-Function Mutation, Val340Met, in a Family With Autosomal Dominant Hypocalcemia Type 2 (ADH2).
Journal article
Piret SE. et al, (2016), J Bone Miner Res, 31, 1207 - 1214
Allosteric Modulation of the Calcium-sensing Receptor Rectifies Signaling Abnormalities Associated with G-protein α-11 Mutations Causing Hypercalcemic and Hypocalcemic Disorders.
Journal article
Babinsky VN. et al, (2016), J Biol Chem, 291, 10876 - 10885
Cinacalcet for Symptomatic Hypercalcemia Caused by AP2S1 Mutations.
Journal article
Howles SA. et al, (2016), N Engl J Med, 374, 1396 - 1398
Adaptor protein-2 sigma subunit mutations causing familial hypocalciuric hypercalcaemia type 3 (FHH3) demonstrate genotype-phenotype correlations, codon bias and dominant-negative effects.
Journal article
Hannan FM. et al, (2015), Hum Mol Genet, 24, 5079 - 5092
Mutational analysis of the adaptor protein 2 sigma subunit (AP2S1) gene: search for autosomal dominant hypocalcemia type 3 (ADH3).
Journal article
Rogers A. et al, (2014), J Clin Endocrinol Metab, 99, E1300 - E1305
Kidney stones: a fetal origins hypothesis.
Journal article
Howles SA. et al, (2013), J Bone Miner Res, 28, 2535 - 2539
Familial Hypocalciuric Hypercalcaemia Type 3 (FHH3) Identified in a Family in Northern Ireland Leading to Identification of a Causative Mutation in the Adaptor Protein 2 Sigma 1 (AP2S1) Gene
Journal article
Graham UM. et al, (2013), IRISH JOURNAL OF MEDICAL SCIENCE, 182, S421 - S421
Mutations affecting G-protein subunit α11 in hypercalcemia and hypocalcemia.
Journal article
Nesbit MA. et al, (2013), N Engl J Med, 368, 2476 - 2486
Gain-of-Function Mutations in G alpha 11 Cause a Novel Form of Autosomal-Dominant Hypoparathyroidism
Journal article
Mannstadt M. et al, (2013), JOURNAL OF BONE AND MINERAL RESEARCH, 28